These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 20883704)

  • 21. p53 enters the microRNA world.
    Hermeking H
    Cancer Cell; 2007 Nov; 12(5):414-8. PubMed ID: 17996645
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The impact of miR-34a on protein output in hepatocellular carcinoma HepG2 cells.
    Cheng J; Zhou L; Xie QF; Xie HY; Wei XY; Gao F; Xing CY; Xu X; Li LJ; Zheng SS
    Proteomics; 2010 Apr; 10(8):1557-72. PubMed ID: 20186752
    [TBL] [Abstract][Full Text] [Related]  

  • 23. miR-10 in development and cancer.
    Lund AH
    Cell Death Differ; 2010 Feb; 17(2):209-14. PubMed ID: 19461655
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells.
    Welch C; Chen Y; Stallings RL
    Oncogene; 2007 Jul; 26(34):5017-22. PubMed ID: 17297439
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dysregulation of microRNA-34a expression causes drug-resistance to 5-FU in human colon cancer DLD-1 cells.
    Akao Y; Noguchi S; Iio A; Kojima K; Takagi T; Naoe T
    Cancer Lett; 2011 Jan; 300(2):197-204. PubMed ID: 21067862
    [TBL] [Abstract][Full Text] [Related]  

  • 26. miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells.
    Li N; Fu H; Tie Y; Hu Z; Kong W; Wu Y; Zheng X
    Cancer Lett; 2009 Mar; 275(1):44-53. PubMed ID: 19006648
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA miR-183 functions as an oncogene by targeting the transcription factor EGR1 and promoting tumor cell migration.
    Sarver AL; Li L; Subramanian S
    Cancer Res; 2010 Dec; 70(23):9570-80. PubMed ID: 21118966
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MiR-34a attenuates paclitaxel-resistance of hormone-refractory prostate cancer PC3 cells through direct and indirect mechanisms.
    Kojima K; Fujita Y; Nozawa Y; Deguchi T; Ito M
    Prostate; 2010 Oct; 70(14):1501-12. PubMed ID: 20687223
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of microRNA-34a in cell cycle, differentiation, and apoptosis: a review.
    Chen F; Hu SJ
    J Biochem Mol Toxicol; 2012 Feb; 26(2):79-86. PubMed ID: 22162084
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The tumor suppressor gene RhoBTB1 is a novel target of miR-31 in human colon cancer.
    Xu RS; Wu XD; Zhang SQ; Li CF; Yang L; Li DD; Zhang BG; Zhang Y; Jin JP; Zhang B
    Int J Oncol; 2013 Feb; 42(2):676-82. PubMed ID: 23258531
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer.
    Toyota M; Suzuki H; Sasaki Y; Maruyama R; Imai K; Shinomura Y; Tokino T
    Cancer Res; 2008 Jun; 68(11):4123-32. PubMed ID: 18519671
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Initial study of microRNA expression profiles of colonic cancer without lymph node metastasis.
    Wang YX; Zhang XY; Zhang BF; Yang CQ; Chen XM; Gao HJ
    J Dig Dis; 2010 Feb; 11(1):50-4. PubMed ID: 20132431
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Differential expression of colon cancer microRNA in microarry study].
    Ma Q; Yang L; Wang C; Yu YY; Zhou B; Zhou ZG
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 May; 42(3):344-8. PubMed ID: 21826996
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of lactate dehydrogenase A by microRNA-34a resensitizes colon cancer cells to 5-fluorouracil.
    Li X; Zhao H; Zhou X; Song L
    Mol Med Rep; 2015 Jan; 11(1):577-82. PubMed ID: 25333573
    [TBL] [Abstract][Full Text] [Related]  

  • 35. microRNA-34 family and treatment of cancers with mutant or wild-type p53 (Review).
    Wong MY; Yu Y; Walsh WR; Yang JL
    Int J Oncol; 2011 May; 38(5):1189-95. PubMed ID: 21399872
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased microRNA-34b and -34c predominantly expressed in stromal tissues is associated with poor prognosis in human colon cancer.
    Hiyoshi Y; Schetter AJ; Okayama H; Inamura K; Anami K; Nguyen GH; Horikawa I; Hawkes JE; Bowman ED; Leung SY; Harris CC
    PLoS One; 2015; 10(4):e0124899. PubMed ID: 25894979
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A p53-inducible microRNA-34a downregulates Ras signaling by targeting IMPDH.
    Kim HR; Roe JS; Lee JE; Hwang IY; Cho EJ; Youn HD
    Biochem Biophys Res Commun; 2012 Feb; 418(4):682-8. PubMed ID: 22301190
    [TBL] [Abstract][Full Text] [Related]  

  • 38. miR-34a Regulates Multidrug Resistance via Positively Modulating OAZ2 Signaling in Colon Cancer Cells.
    Li Y; Gong P; Hou JX; Huang W; Ma XP; Wang YL; Li J; Cui XB; Li N
    J Immunol Res; 2018; 2018():7498514. PubMed ID: 30175154
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SIRT1 modulates miRNA processing defects in p53-mutated human keratinocytes.
    Herbert KJ; Cook AL; Snow ET
    J Dermatol Sci; 2014 May; 74(2):142-9. PubMed ID: 24548601
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-143 and -145 in colon cancer.
    Akao Y; Nakagawa Y; Naoe T
    DNA Cell Biol; 2007 May; 26(5):311-20. PubMed ID: 17504027
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.